GSK Bets Nearly $1.3 Billion on Hutchmed’s ATTC Platform as Chinese Innovative Drugs Enter the “Selling the Platform” Era — BigGo Finance
British pharmaceutical giant GSK and Chinese innovative drugmaker Hutchmed have reached a licensing agreement worth up to $1.295…